Previous Article | Next Article ![]()
Infection and Immunity, November 1999, p. 5559-5566, Vol. 67, No. 11
Institut National de la Santé et de la
Recherche Médicale, INSERM U 399, Laboratoire de
Parasitologie, Faculté de Médecine, Université de
la Méditerranée, Marseille, France
Received 22 March 1999/Returned for modification 18 May
1999/Accepted 12 August 1999
Visceral leishmaniasis is a severe and lethal disease caused by the
protozoan parasites of the genus Leishmania. In areas where
leishmaniasis is endemic, most infected individuals control the
infection and remain asymptomatic; chemotherapy of visceral leishmaniasis restores some immunity which protects against relapses. In the present study, Leishmania-specific T-cell clones
were established from six asymptomatic and five cured patients.
Cytokines production by these clones was analyzed. A large fraction of
the parasite-specific T-cell clones from asymptomatic patients were
CD8+ and produced high amounts of gamma interferon
(IFN-
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Control of Leishmania infantum Infection Is Associated
with CD8+ and Gamma Interferon- and
Interleukin-5-Producing CD4+ Antigen-Specific T
Cells
). Most CD4+ T-cell clones from two asymptomatic
subjects exhibited an unusual phenotype: production of high levels of
IFN-
low levels of interleukin-4, (IL-4), but high levels of IL-5.
In contrast, only few parasite-specific CD8+ T-cell clones
were obtained from cured patients after chemotherapy; moreover,
CD4+ T-cell clones from these patients exhibited an
heterogeneous profile of cytokines from Th1-like to Th2-like
phenotypes. These results point to CD8+ T cells and to
IL-5- and IFN-
-producing CD4+ T cells as possible
contributors to human resistance to Leishmania infection.
They should stimulate new immunological approaches in the control of
this disease.
*
Corresponding author. Mailing address: Institut
National de la Santé et de la Recherche Médicale, INSERM U
399, Laboratoire de Parasitologie, Faculté de Médecine, 27 Blvd. Jean Moulin, 13385 Marseille Cedex 5, France. Phone:
33-4-91-32-44-55. Fax: 33-4-91-79-60-63. E-mail:
charles.mary{at}medecine.univ-mrs.fr.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»